Regeneron (NASDAQ: REGN) legal chief exercises 12,282 options
Rhea-AI Filing Summary
REGENERON PHARMACEUTICALS, INC. (REGN) reported insider equity transactions by Joseph J. LaRosa, EVP General Counsel and Secretary. On 2026-08-19, he exercised a non-qualified stock option for 12,282 shares of common stock at an exercise price of $381.92 per share, from an award that vested in four equal annual installments commencing one year after grant. He acquired 12,282 common shares upon exercise and 9,019 shares of common stock at $830.15 per share were delivered or withheld for payment of exercise price or tax liability. Following the transaction, he directly held 12,283 non-qualified stock options expiring on 2026-12-16 and indirect common stock holdings of 3,402 shares via a 2024 GRAT, 5,407 shares via a 2025 GRAT, and 413 shares through a 401(k) plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 3,263 shares
Net Buy
6 txns
Insider
LAROSA JOSEPH J
Role
EVP General Counsel and Secret
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (right to buy) F1 | 12,282 | $0.00 | $0.00 |
| Exercise | Common Stock | 12,282 | $381.92 | $4.69M |
| Exercise Price or Tax Liability | Common Stock | 9,019 | $830.15 | $7.49M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Non-Qualified Stock Option (right to buy) — 12,283 shares (Direct);
Common Stock — 36,373 shares (Direct);
Common Stock — 3,402 shares (Indirect, By 2024 GRAT);
Common Stock — 5,407 shares (Indirect, By 2025 GRAT);
Common Stock — 413 shares (Indirect, By 401(k) Plan)
Footnotes (1)
- F1. The stock option award vested in four equal annual installments, commencing one year after the date of grant.
Key Figures
Options exercised: 12,282 shares
Option exercise price: $381.92 per share
Shares delivered/withheld for exercise price or tax liability: 9,019 shares at $830.15 per share
+5 more
8 metrics
Options exercised
12,282 shares
Non-qualified stock option exercise on 2026-08-19
Option exercise price
$381.92 per share
Non-qualified stock option on REGN common stock
Shares delivered/withheld for exercise price or tax liability
9,019 shares at $830.15 per share
Common stock used in connection with option exercise
Remaining non-qualified stock options
12,283 options
Directly held after the reported transactions
Option expiration date
2026-12-16
Non-qualified stock option on REGN common stock
Indirect holding by 2024 GRAT
3,402 shares
REGN common stock held indirectly
Indirect holding by 2025 GRAT
5,407 shares
REGN common stock held indirectly
Indirect holding by 401(k) Plan
413 shares
REGN common stock held through retirement plan
Key Terms
Non-Qualified Stock Option, Grantor Retained Annuity Trust (GRAT), 401(k) Plan, Payment of exercise price or tax liability
4 terms
Non-Qualified Stock Option financial
"security_title: "Non-Qualified Stock Option (right to buy)""
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
Grantor Retained Annuity Trust (GRAT) financial
"nature_of_ownership: "By 2024 GRAT" and "By 2025 GRAT""
401(k) Plan financial
"nature_of_ownership: "By 401(k) Plan""
A 401(k) plan is a workplace retirement account that lets employees set aside part of their pay into a tax-advantaged savings pot, often with employers adding matching contributions — like a workplace piggy bank for future income. It matters to investors because the amount people save and how employers fund these plans influence consumer spending, corporate payroll costs and the flow of money into financial markets, which can affect stock prices and company valuations.
Payment of exercise price or tax liability financial
"transaction_code_description for code F transaction"
FAQ
What did REGN executive Joseph J. LaRosa report in this Form 4?
He exercised a non-qualified stock option for 12,282 REGN shares at $381.92 per share, acquired 12,282 common shares, and had 9,019 shares delivered or withheld at $830.15 per share for payment of exercise price or tax liability.
How many Regeneron (REGN) options does Joseph J. LaRosa hold after the transaction?
After the transaction, Joseph J. LaRosa held 12,283 non-qualified stock options on REGN common stock, with an expiration date of 2026-12-16, as reported in the Form 4.
How did the exercised REGN option held by Joseph J. LaRosa vest?
The non-qualified stock option award vested in four equal annual installments, commencing one year after the date of grant, according to the footnote in the Form 4.
AI-generated analysis. How Rhea-AI works. Not financial advice.
